Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001596771-18-000072
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-05 17:14:35
Reporting Period:
2018-06-01
Accepted Time:
2018-06-05 17:14:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1610092 Diplomat Pharmacy Inc. DPLO Retail-Drug Stores And Proprietary Stores (5912) 382063100
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1617239 Shawn Tomasello 4100 S. Saginaw St.
Flint MI 48507
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-01 3,654 $0.00 12,816 No 4 A Direct
Common Stock Disposition 2018-06-05 1,680 $24.27 11,136 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Footnotes
  1. The shares of restricted stock were granted in connection with the Issuer's non-employee director compensation program.
  2. The sales reported in this Form 4 represent shares sold to cover the tax liability incurred incident to the vesting of previously granted restricted stock.
  3. The price represents the weighted average price of the multiple transactions reported on this line. The shares were sold at prices ranging from $24.2101 to $24.46. Upon request by the SEC staff, the Issuer or any securityholder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.